These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 11095341

  • 41. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis.
    Nakazawa T, Ohara H, Sano H, Ando T, Aoki S, Kobayashi S, Okamoto T, Nomura T, Joh T, Itoh M.
    Pancreas; 2005 Jan; 30(1):20-5. PubMed ID: 15632695
    [Abstract] [Full Text] [Related]

  • 42. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
    Bedlow AJ, Donaldson PT, McFarlane BM, Lombard M, McFarlane IG, Williams R.
    J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
    [Abstract] [Full Text] [Related]

  • 43. Primary sclerosing cholangitis can present with acute liver failure: Report of two cases.
    Bergquist A, Glaumann H, Lindberg B, Broomé U.
    J Hepatol; 2006 May; 44(5):1005-8. PubMed ID: 16551483
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.
    Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, Chari S, Lindor KD.
    Am J Gastroenterol; 2006 Sep; 101(9):2070-5. PubMed ID: 16879434
    [Abstract] [Full Text] [Related]

  • 46. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases.
    Martins EB, Graham AK, Chapman RW, Fleming KA.
    Hepatology; 1996 May; 23(5):988-93. PubMed ID: 8621180
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Autoimmune hepatitis and primary sclerosing cholangitis: dependent or independent association?].
    Guerrero-Hernández I, Montaño-Loza A, Gallegos-Orozco JF, Weimersheimer-Sandoval M.
    Rev Gastroenterol Mex; 2007 May; 72(3):240-3. PubMed ID: 18402214
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Autoimmune cholangitis within the spectrum of autoimmune liver disease.
    Czaja AJ, Carpenter HA, Santrach PJ, Moore SB.
    Hepatology; 2000 Jun; 31(6):1231-8. PubMed ID: 10827147
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease.
    Okada H, Mizuno M, Yamamoto K, Tsuji T.
    Acta Med Okayama; 1996 Oct; 50(5):227-35. PubMed ID: 8914675
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis.
    Björnsson E, Angulo P.
    Am J Gastroenterol; 2007 Aug; 102(8):1677-82. PubMed ID: 17433022
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
    Weismüller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP.
    J Hepatol; 2008 Aug; 48 Suppl 1():S38-57. PubMed ID: 18304683
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN, Blanchard JF, Rawsthorne P, Yu N.
    Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.